Evidence map›Paper›PMID 40456931›Full record

ArticlePediatric nephrology (Berlin, Germany)2025

Expanded CRB2-related disease phenotype: multisystem involvement and post-transplant complications in monozygotic twins.

Moran Plonsky Toder, Shirley Pollack, Rami Tibi, Irina Libinson-Zebegret, Renata Yakubov, Israel Eisenstein, Mika Shapira Rootman, Daniella Magen

Abstract readCase Reports
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Moran Plonsky ToderTechnion Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel. m.plonsky@technion.ac.il.ORCID 0009-0003-8489-715X
Shirley PollackTechnion Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel.
Rami TibiRuth Rappaport Children's Hospital, Rambam Health Care Campus, Pediatric Nephrology Institute, Haifa, Israel.
Irina Libinson-ZebegretRuth Rappaport Children's Hospital, Rambam Health Care Campus, Pediatric Nephrology Institute, Haifa, Israel.
Renata YakubovTechnion Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel.
Israel EisensteinTechnion Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel.
Mika Shapira RootmanTechnion Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel.
Daniella MagenTechnion Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel.

Funding

Technion - Israel Institute of Technology
6 · The paper itself

Abstract

backgroundCongenital nephrotic syndrome (CNS) is a rare disorder caused by mutations in genes essential for podocyte function and glomerular slit diaphragm integrity, including CRB2 (Crumbs Cell Polarity Complex Component 2). CRB2 mutations are linked to focal segmental glomerulosclerosis and ventriculomegaly with cystic kidney disease, but their full phenotypic spectrum remains unclear. We describe the clinical course of monozygotic twins with a homozygous CRB2 mutation, highlighting severe complications following kidney transplantation.

methodsThe twins, who were followed and managed throughout their clinical course, were diagnosed with CNS after prenatal suspicion of polycystic kidney disease. Initial exome sequencing was negative, but subsequent whole exome sequencing revealed a homozygous CRB2 variant.

resultsBoth twins presented with CNS, requiring intensive supportive care. Additional findings included cerebral heterotopia, cardiac involvement, and developmental delay. They both progressed to kidney failure, necessitating hemodialysis in early childhood. Post-transplant, the first twin succumbed to a systemic fungal infection, while the second developed complications linked to immune dysregulation, including post-transplant lymphoproliferative disease (PTLD), immune thrombocytopenic purpura (ITP), multiple viremias, and de novo donor-specific antibodies (DSA).

conclusionsThis case expands the phenotypic spectrum of CRB2-related disease, highlights management challenges, and underscores the need for genetic re-analysis in rare diseases. Further research is required to understand CRB2-related mechanisms.

Indexed as

Kidney TransplantationMembrane ProteinsNephrotic SyndromePostoperative ComplicationsCarrier ProteinsChild, PreschoolExome SequencingFatal OutcomeFemaleHomozygoteHumansInfantMutationPhenotypeTwins, MonozygoticCarrier ProteinsCRB2 protein, humanMembrane ProteinsCongenital nephrotic syndromeCRB2 mutationPediatric kidney transplantation

Identifiers

PMID40456931
PMCPMC12401768

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.